this reads well
Spodumene sales of 76,631 dmt generated record revenue of ~US$201.1 million5 with a gross
cash margin of 71% at average sales price of approximately US$3,000/dmt on a SC6 CIF basis
- Forums
- ASX - By Stock
- AKE
- Ann: September quarterly activities report
Ann: September quarterly activities report, page-2
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AKE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online